Why the study?
MINOCA represents 6-8% of MI patients and carries significant mortality and morbidity, but trial results evaluating diagnostic algorithms and acute/long-term management are pending.
Answers are grounded in this paper and cite their sources.
This review highlights the clinical features, diagnostic work-up, and therapeutic management of MINOCA, emphasizing the need for precision medicine and pending results from randomized clinical trials.
PURPOSE OF REVIEW: Myocardial infarction with nonobstructive coronary arteries (MINOCA) represents about 6-8% of all patients with myocardial infarction (MI), and several pathophysiological mechanisms showed to be involved in this heterogeneous clinical condition. Of note, MINOCA proved to be associated with a significant risk of mortality, angina burden and socioeconomic costs. RECENT FINDINGS: Results from randomized clinical trials evaluating the clinical effectiveness of a comprehensive diagnostic algorithm, along with the acute and long-term management of patients with MINOCA, are pending. SUMMARY: In this review article, we aim at providing an overview of the clinical features, diagnostic work-up and the therapeutic management of patients presenting with MINOCA, highlighting the recent acquisition along with the remaining important knowledge gaps in this field.
No takes yet. Share an insight, caveat, or question.
Buono et al. (2022) conducted a review in Myocardial infarction with nonobstructive coronary arteries (MINOCA).
Synapse has enriched 10 related papers. Consider them for comparative context: